AngioDynamics (ANGO) Misses On Earnings & Revenues In Q1
Zacks Investment Research | Oct 01, 2017 10:08PM ET
AngioDynamics Inc. (NASDAQ:ANGO) reported adjusted earnings of 12 cents per share in the first quarter of fiscal 2018. Earnings missed the Zacks Consensus Estimate by 4 cents and decreased 29.4% year over year. Meanwhile, net sales fell almost 3.4% on a year-over-year basis to $85.4 million, missing the Zacks Consensus Estimate of $86 million.
It is important to note that foreign exchange did not have any impact in the reported quarter. However, continued softness in the Vascular Access and Venous business affected revenues in the first quarter.
Internationally, AngioDynamics registered revenues of $16.5 million, up from $15.9 million in the year-ago quarter. International growth was strengthened by solid sales from the Oncology and Surgery business. However, the company registered $68.9 million revenues in the United States, down from $72.2 million on a year-over-year basis. The lackluster performance was led by softness in the venous business, which was more or less muted by growth in the oncology portfolio.
AngioDynamics, Inc. Price, Consensus and EPS Surprise
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.